A propos de votre organisation

ExactCure develops a Digital Health solution to properly use drugs. Our Digital Twin simulates the concentration of drugs in the blood of a patient based on his/her personal characteristics in order to avoid under-doses, overdoses and drug-drug interactions. Our disruptive technology is based on fundamental research.

 

We provide Personalised Drug Simulations as a Service. Thanks to our API, third-party platforms can integrate our simulations into their solution towards healthcare professionals and patients.

 

We developed our own end-user interfaces, that can be white-labelled (download ExaMed: Android or iOS).

 

Our solution is a Medical Device.

 

In 2021 our revenue grew by 50% vs 2020, and during Q1'22 our revenue represented 104% of FY'2021. Our customers include UPSA (download Med&Moi: Android or iOS), Vidal, Elsevier and US-based Tabula Rasa Healthcare.

 

We are a member of an international H2020 project on in silico simulations for clinical trials on cardio-vascular diseases. ExactCure was mentioned in an article by the Harvard Business Review, and the MIT invited us to be a speaker at their "AI for Healthcare" summit.

 

We expand our drug coverage chronic disease by chronic disease.

 

Our MISSION is to provide personalized drug simulations to healthcare professionals and patients.

Our VISION is a world where medication errors are a thing of the past.

Our AMBITION is to become the worldwide reference in personalized medication simulations.

Actualités

Réseau (0)

Il n'y a pas encore d'organisations dans le réseau.

Activité récente

Vous n'êtes pas connecté(e)

Un certain nombre de contenus vous sont cachés et vous ne bénéficiez pas des fonctionnalités de mises en relation.

Log in or register pour accéder à l’intégralité des contenus et fonctionnalités d’EuroQuity : l’inscription est rapide et gratuite !